[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-viking-therapeutics-nasdaqvktx3301924ec1-d04f-7db3-ae66-b266f682e121":3},{"id":4,"timestamp":5,"title":6,"content":6,"link":7,"preview":8,"tags":9,"predictedTags":9,"showTags":9,"source":10,"reactions":11,"selfReactions":12,"logo":13,"sourceId":14,"sourceUserId":15,"asset":16,"tagsCategories":17,"totalComments":18,"lang":19,"unique_views_count":20,"enrichStatus":16,"triageKind":15,"triageImportance":15,"expandEligible":15,"summarizeEligible":15,"eventEligible":15,"eventType":15,"eventAction":15},"viking-therapeutics-nasdaqvktx3301924ec1-d04f-7db3-ae66-b266f682e121","1727897440000","Viking Therapeutics (NASDAQ:VKTX) Trading Up 1.2%","https://www.marketbeat.com/instant-alerts/nasdaq-vktx-percent-advance-2024-10-02/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","3"]